Authors:
Goodacre, S
Morris, F
Campbell, S
Quinney, D
Capewell, S
Citation: S. Goodacre et al., Diagnosing myocardial infarction - Randomised controlled trial and economic evaluation of a chest pain unit are in progress, BR MED J, 323(7325), 2001, pp. 1366-1366
Authors:
Goodacre, S
Mason, S
Arnold, J
Angelini, K
Citation: S. Goodacre et al., Psychologic morbidity and health-related quality of life of patients assessed in a chest pain observation unit, ANN EMERG M, 38(4), 2001, pp. 369-376
Citation: S. Goodacre et al., Do computer generated ECG reports improve interpretation by accident and emergency senior house officers?, POSTG MED J, 77(909), 2001, pp. 455-457
Authors:
Rowley, M
Hallett, DJ
Goodacre, S
Moyes, C
Crawforth, J
Sparey, TJ
Patel, S
Marwood, R
Patel, S
Thomas, S
Hitzel, L
O'Connor, D
Szeto, N
Castro, JL
Hutson, PH
MacLeod, AM
Citation: M. Rowley et al., 3-(4-fluoropiperidin-3-yl)-2-phenylindoles as high affinity, selective, and orally bioavailable h5-HT2A receptor antagonist, J MED CHEM, 44(10), 2001, pp. 1603-1614
Authors:
Helgason, A
Hickey, E
Goodacre, S
Bosnes, V
Stefansson, K
Ward, R
Sykes, B
Citation: A. Helgason et al., mtDNA and the islands of the north atlantic: Estimating the proportions ofNorse and Gaelic ancestry, AM J HU GEN, 68(3), 2001, pp. 723-737
Authors:
Crawforth, J
Goodacre, S
Maxey, R
Bourrain, S
Patel, S
Marwood, R
O'Connor, D
Herbert, R
Hutson, P
Rowley, M
Citation: J. Crawforth et al., 3-(4-piperidinyl)- and 3-(8-aza-bicyclo[3.2.1]oct-3-yl)-2-phenyl-1H-indoles as bioavailable h5-HT2A antagonists, BIOORG MED, 10(24), 2000, pp. 2701-2703
Authors:
Chambers, MS
Street, LJ
Goodacre, S
Hobbs, SC
Hunt, P
Jelley, RA
Matassa, VG
Reeve, AJ
Sternfeld, F
Beer, MS
Stanton, JA
Rathbone, D
Watt, AP
MacLeod, AM
Citation: Ms. Chambers et al., 3-(piperazinylpropyl)indoles: Selective, orally bioavailable h5-HT1D receptor agonists as potential antimigraine agents, J MED CHEM, 42(4), 1999, pp. 691-705